University of California, Los Angeles
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Los Angeles sits in the top decile of US sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count).
University of California, Los Angeles: 897 sponsored US clinical trials, 158 recruiting.
University of California, Los Angeles sponsors 897 registered US clinical trials on ClinicalTrials.gov, 158 of them currently recruiting, and 622 completed. 98 of these trials are in Phase 3-4 (later-stage) and 194 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of California, Los Angeles ranks in the top decile of sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
622 of 679 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
897 total, page 11 of 18
Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine
NCT02505477
Study to Compare Palindrome vs. BioFlo DuraMax Dialysis Catheters
NCT02796300
E-cigarettes, Nicotine Inhaler, and Blood Vessel Function
NCT03072628
Reminder Focused Positive Psychiatry in Adolescents With ADHD and PTSD
NCT04336072
Effectiveness of Changing Dietary Fat on Weight Loss
NCT02953158
Identification and Removal of the Non Palpable Etonogestrel Contraceptive Implant
NCT02986204
Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID
NCT02999984
Invasive Approach to Model Human Cortex-Basal Ganglia Action-Regulating Networks
NCT03608228
MRA With Feraheme in HHT
NCT02977637
Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode
NCT02823041
Grade Book Game Evaluation Among 6th Grade Students
NCT03039894
Effects of Branch Chain Amino Acids on Glucose Tolerance in Obese Pre-Diabetic Subjects
NCT02684565
Characterization of the Analgesic Effect of CBD in Healthy, Normal Volunteers
NCT02751359
Ocular Imaging Study Using Advanced OCT
NCT02827071
Trial of Levomilnacipran in Geriatric Depression
NCT02466958
Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women
NCT02584140
Combining Varenicline and Naltrexone for Smoking Cessation
NCT02698215
Cord Milking Impacts Neurodevelopmental Outcomes in Very Low Birth Weight Infants
NCT02987764
Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks
NCT03153371
Investigation of an Amino Acid Supplement on Glucose Levels in Obese Subjects
NCT03715010
Thalamic Low Intensity Focused Ultrasound in Brain Injury
NCT02522429
Nanodiamond Modified Gutta Percha (NDGP) Composite for Non-surgical Root Canal Therapy (RCT) Filler Material
NCT02698163
The Impact of Family Financial Support on Cognition
NCT02723318
The Impact of Family Financial Support on Child Health
NCT02770144
Effectiveness of CES on Emotional and Cellular Wellbeing
NCT03369418
The Impact of Family Financial Support on Parental Stress
NCT02723227
The Impact of Family Financial Support on Health Related Quality of Life
NCT02722005
The Impact of Family Financial Support on Parental Mental Health
NCT02723357
H3: Healthy Minds, Healthy Children, Healthy Chicago Project Evaluation
NCT02699814
Musculoskeletal Ultrasound Assessment of Therapeutic Response of Tofacitinib in Rheumatoid Arthritis Patients
NCT02321930
Participatory Messaging in the UCLA Psychiatry Partial Hospitalization and Intensive Outpatient Programs
NCT02708940
Mobile Self-Management of Irritable Bowel Syndrome for Adolescents
NCT03138980
A Behavioral Intervention for Pain Catastrophizing in Primary Dysmenorrhea
NCT02640079
Effectiveness of Peer Navigation and Contingency Management on Retention in HIV Care
NCT02310893
Phenotyping IBS: Perceptions and Modulations of Visceral Sensations
NCT02693730
Brain Connectivity and Response to Tai Chi in Geriatric Depression
NCT02460666
Anxiety and Reward Interaction and Prediction of Outcomes in Anorexia Nervosa
NCT02948452
Remote Preconditioning Over Time To Empower Cerebral Tissue
NCT02169739
Study of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous Disease
NCT02234934
Imaging Innovations for Placental Assessment in Response to Environmental Pollution (PARENTs)
NCT02786420
Writing About Experiences and Health in Older Adults
NCT02472379
The Effect of Pomegranate on Aging and Inflammation of the Skin
NCT02258776
Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo
NCT02582515
Abatacept for SLE Arthritis (IM101-330)
NCT02429934
Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex
NCT02687633
A Brief Laboratory-Based Hypnosis Session for Pain in Sickle Cell Disease
NCT02620488
Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System
NCT02797262
Web-based Preconception Health Education Tool
NCT02529527
Optimizing Exposure Therapy for Anxiety Disorders
NCT04048824
E-cigarettes and Blood Vessel Function
NCT02740595
What is open in the University of California, Los Angeles pipeline
158 recruiting of 897 indexed (18% open); 622 completed (69%).
Phase mix: 98 late (III/IV) vs 194 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Los Angeles: open-pipeline peers nationwide
Peers matched on 897 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, Los Angeles sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 897 trials (± recruiting share)
- Indiana University · 890 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- ConvaTec · 18% recruiting · 17 trials
- Endologix · 18% recruiting · 17 trials
- National Institute on Deafness and Other Communication Disorders (NIDCD) · 18% recruiting · 34 trials
- NICHD Pelvic Floor Disorders Network · 18% recruiting · 17 trials
Related
What to do with this University of California, Los Angeles page
897 registered trials is a research-attention snapshot, not an endorsement of University of California, Los Angeles or any single study.
- 158 of University of California, Los Angeles's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of California, Los Angeles studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Los Angeles pipeline card: 897 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.